Now available LEQEMBI™

LEQEMBI™ (lecanemab-irmb) is indicated for the treatment of Alzheimer's disease.Treatment with LEQEMBI should be initiated in patients with mild cognitive impairment ormild dementia stage of disease, the population in which treatment was initiated in clinicaltrials.